Colorectal cancer has a 90% survival rate with early detection. So the "Deadpool & Wolverine" star shared his colonoscopy ...

The noninvasive test provides a beneficial screening tool for patients 45 and older at average risk for colorectal cancer.

Who needs to worry about colon cancer, and what tests will we be able to use in the future for early cancer detection?

The approval was based on data from the BLUE-C trial, which assessed the sensitivity and specificity of the Cologuard Plus test vs FIT in asymptomatic adults scheduled for screening colonoscopy.

Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with the risk for retained gastric contents ...

Colon cancers are increasing among younger Americans, so much so that experts advise colonoscopy screening begin at the age ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the U.S.

Exact Sciences' Cologuard Plus test, now FDA-approved, offers a non-invasive screening option for adults 45+ at average risk for colorectal cancer. The test outperformed fecal immunochemical tests in ...

FDA approves Exact Sciences' non-invasive Cologuard Plus test for colorectal cancer detection in adults at average risk.

Soon there could be a blood test to screen for colon cancer, and that could help people get tested without a colonoscopy or ...

Colon cancers are increasing among younger Americans, so much so that experts advised in 2021 that colonoscopy screenin ...

The company says the enhanced sensitivity will help minimize unnecessary follow-up colonoscopy procedures by reducing the ...